Administration of a Nucleoside Analog Promotes Cancer Cell Death in a Telomerase-Dependent Manner

Abstract excerpt

Telomerase, the end-replication enzyme, is reactivated in malignant cancers to drive cellular immortality. While this distinction makes telomerase an attractive target for anti-cancer therapies, most approaches for inhibiting its activity have been clinically ineffective. As opposed to inhibiting telomerase, we use its activity to selectively promote cytotoxicity in cancer cells. We show that several nucleotide...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Advanced biosensing and bioanalysis techniques
• Share to DNA Repair Mechanisms
• Share to Telomeres, Telomerase, and Senescence